Clinical trials for authorized biosimilars in the European Union: a systematic review
Clinical trials for authorized biosimilars in the European Union: a systematic review
In 2006, Omnitrope (by Sandoz) was the first approved biosimilar in Europe. To date, 21 biosimilars for seven different biologics are on the market. The present study compared the clinical trials undertaken to obtain market authorization.We summarized the findings of a comprehensive review of all clinical trials up to market …